What is FORMULATRIX?
Founded in 2002 and headquartered in Bedford, Massachusetts, FORMULATRIX specializes in the research and development of sophisticated instrumentation for the life science industry. The company's core portfolio includes advanced protein crystallization software, automated drop setters, and high-throughput liquid handling systems. These technologies are essential for pharmaceutical and biotech research, enabling scientists to accelerate drug discovery through precise, automated workflows. By bridging the gap between complex biological research and scalable laboratory automation, FORMULATRIX has established itself as a foundational partner for organizations seeking to optimize their experimental throughput and data accuracy.
How much funding has FORMULATRIX raised?
FORMULATRIX has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in FORMULATRIX
PPP
Public-Private Partnership
What's next for FORMULATRIX?
With this major enterprise-level funding, FORMULATRIX is well-positioned to expand its technological footprint and deepen its market penetration. The strategic allocation of this capital will likely focus on enhancing the integration of its software suites with existing laboratory hardware, further streamlining the research lifecycle for its global client base. As the demand for automated drug discovery tools continues to rise, the company is expected to prioritize R&D initiatives that push the boundaries of liquid handling precision. This growth phase signals a transition toward broader market dominance, as the firm leverages its established reputation to capture emerging opportunities in the rapidly evolving biotech landscape.
See full FORMULATRIX company page
